VRC-HIVADV014-00-VP

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVRC-HIVADV014-00-VP
Drug Alias NamerAd5 gag-pol/env A/B/C vaccineHIV adenovector serotype Ad5 vaccine - GenVec/NIAIDVRC-HIV-rAd5Ad5HIV-EnvAVRC-HIVADV014-00-VP
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUgandaRwanda +[11] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenvec LlcNational Institute Of Allergy And Infectious Diseases (Niaid)Nih Vaccine Research Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNih Vaccine Research CenterGenvec LlcNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A